[The effect of obzidan on the central and hepatic portal hemodynamics in patients with liver cirrhosis].
Rusyn
V I
VI
Peresta
Iu Iu
IuIu
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D000328:Adult; D004932:Esophageal and Gastric Varices / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011168:Portal System / Q000187:drug effects* / Q000503:physiopathology; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*; D012016:Reference Values
D000319:Adrenergic beta-Antagonists; D011433:Propranolol
Vplyv obzydanu na tsentral'nu ta voritno-pechinkovu hemodynamiku u khvorykh z tsyrozom pechinky.